HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Marsden, D. Articles by Larson, C. A. Search for Related Content PubMed PubMed Citation Articles by Marsden, D. Articles by Larson, C. A. Related Collections Pediatric Clinical Chemistry Endocrinology and Metabolism Automation and Analytical Techniques

Emerging Role for Tandem Mass Spectrometry in Detecting Congenital Adrenal Hyperplasia

¹ Children’s Hospital Boston, Boston, MA 02115² New England Newborn Screening Program, Jamaica Plain, MA 02130

^aAuthor for correspondence. Fax 617-730-0466; e-mail deborah.marsden@tch.harvard.edu.

The first 20% of the full text of this article appears below.

Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders caused by a deficiency of one of five enzymes required for the synthesis of cortisol and aldosterone. The most common type of CAH is 21-hydroxylase deficiency (21OHD), which is attributable to mutations in the gene CYP21 and a pseudogene, CYP21P, located on the short arm of chromosome 6. As with other genetic disorders, genotype does not always predict phenotype.

The phenotypic spectrum associated with 21OHD ranges from asymptomatic to early onset (as early as the fourth day of life) of severe salt-wasting crisis characterized by hypotension and electrolyte abnormalities that, if uncorrected, lead to death. Increased androgenic steroids, attributable to accumulated precursors proximal to the enzyme defect, cause ambiguous genitalia in female infants, leading to earlier clinical evaluation in girls. Virilized infant boys, however, are not always recognized, and many will present with acute catastrophic symptoms. Approximately 70% of infants with classic 21OHD have the salt-wasting form.

All newborns in the US are offered medical screening that uses blood collected shortly after birth on filter-paper cards, but the disorders screened for vary from state to state. All US states screen for phenylketonuria (PKU) and congenital hypothyroidism, and 36 states screen for CAH (1). A filter-paper immunoassay to screen for CAH has been available since 1977 (2). This approach relies on measurement of 17-hydroxyprogesterone (17OHP), which is normally converted to 11-deoxycortisol by CYP21 . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				M. M. Kushnir, A. L. Rockwood, W. L. Roberts, E. G. Pattison, W. E. Owen, A. M. Bunker, and A. W. Meikle Development and Performance Evaluation of a Tandem Mass Spectrometry Assay for 4 Adrenal Steroids Clin. Chem., August 1, 2006; 52(8): 1559 - 1567. [Abstract] [Full Text] [PDF]

				S. Kosel, S. Burggraf, R. Fingerhut, H. G. Dorr, A. A. Roscher, and B. Olgemoller Rapid Second-Tier Molecular Genetic Analysis for Congenital Adrenal Hyperplasia Attributable to Steroid 21-Hydroxylase Deficiency Clin. Chem., February 1, 2005; 51(2): 298 - 304. [Abstract] [Full Text] [PDF]

				M. G. Forest Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency Hum. Reprod. Update, November 1, 2004; 10(6): 469 - 485. [Abstract] [Full Text] [PDF]